Glandular kallikrein
Glandular kallikrein is a group of enzymes belonging to the serine protease family, specifically within the S1 family of peptidases (clan PA(S)). These enzymes are known for their role in the processing of various proteins and peptides, including the activation of hormones and other bioactive peptides. Glandular kallikreins are encoded by the KLK genes in humans and are expressed in a wide range of tissues, including the salivary glands, pancreas, and kidneys.
Function[edit | edit source]
Glandular kallikreins play a crucial role in physiological processes such as blood pressure regulation, inflammation, and wound healing. They achieve this by cleaving kininogen to release kinins, peptides that are involved in vasodilation and increased vascular permeability. Additionally, these enzymes are implicated in the processing of prohormones, thereby influencing various hormonal pathways.
Classification[edit | edit source]
The human kallikrein-related peptidase (KLK) family consists of 15 members, ranging from KLK1 to KLK15. Each member exhibits unique expression patterns and substrate specificities, contributing to diverse physiological functions. The most well-known member, KLK3, also known as prostate-specific antigen (PSA), is used clinically as a biomarker for prostate cancer screening and monitoring.
Clinical Significance[edit | edit source]
Beyond their physiological roles, alterations in glandular kallikrein expression and activity have been associated with various diseases. Overexpression or dysregulation of certain KLKs has been linked to cancer progression, particularly in prostate, ovarian, and breast cancers. Consequently, some KLKs are being investigated as potential biomarkers for cancer diagnosis and prognosis, as well as targets for therapeutic intervention.
Research Directions[edit | edit source]
Current research on glandular kallikreins focuses on elucidating their precise roles in health and disease, improving the sensitivity and specificity of KLK-based diagnostic tests, and developing inhibitors that can modulate their activity for therapeutic purposes. Understanding the complex interplay between different KLKs and their substrates is crucial for unlocking their potential in clinical applications.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD